AXS-07 (MoSEIC meloxicam and rizatriptan)

DRUG2 trials

Sponsors

Axsome Therapeutics, Inc.

Conditions

Migraine

Phase 3

Maximizing Outcomes in Treating Acute Migraine

CompletedNCT03896009

Axsome Therapeutics, Inc.Migraine

Start: 2019-03-04End: 2019-12-10Updated: 2023-08-24

Initiating Early Control of Migraine Pain and Associated Symptoms

CompletedNCT04163185

Axsome Therapeutics, Inc.Migraine

Start: 2019-10-08End: 2020-03-23Updated: 2026-01-28